Lynx to Provide Genotyping Technology to Norwegian Fish Genomics Company | GenomeWeb

NEW YORK, April 11 – Lynx Therapeutics will provide its Megasort genotyping technology to GenoMar, a Norwegian marine genomics company, in a collaboration to identify genes in the Tilapia fish associated with saltwater tolerance, the companies said Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.